By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Pen Needles185.5M71.02%
Safety37.3M14.28%
Syringes30.7M11.75%
Contract Manufacturing4.1M1.57%
Other3.6M1.38%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States579.1M53.60%
International501.3M46.40%